ADVERTISEMENTs
Indian researcher receives German Medical Prize
The award recognised her role in developing a new inimally invasive cancer treatment
.jpg)
Dr. Ranjita and prof. Reymond receive the award /
Indian-origin researcher Dr. Ranjita was recently awarded the German Medical Prize together with prof. Reymond for their innovative work in Cancer research.
The two researchers were instrumental in the development of PIPAC (pressurized intraperitoneal aerosolized chemotherapy), a novel therapeutic approach intended to treat ovarian, colorectal, and peritoneal cancers.
According to a news release, the new therapy offers excellent results with far fewer side effects than traditional standard intravenous chemotherapy. It involves new drug delivery carriers that can target cancer cells at various stages of growth and are administered via aerosolization.
“This minimally invasive treatment takes approximately 30 to 90 minutes, followed by if needed an overnight hospital stay. Trial patients undergo the procedure every six weeks for up to six cycles. PIPAC produces minimal side effects because it uses only 10% to 20% of the typical chemotherapy dose,” the release stated
“Studies showed that PIPAC can relieve symptoms of peritoneal metastasis such as lessening pain, ascites and obstructive symptoms, and reduce the side effects of chemotherapy, and thus help improve patients’ quality of life,” it added.
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
.jpg)
E Paper
ADVERTISEMENT
Video
.jpg)
.png)
.png)
.png)
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login